Scandion Oncology AS (STU:8VY)
€ 0.0058 0 (0%) Market Cap: 1.55 Mil Enterprise Value: -408,000.00 PE Ratio: 0 PB Ratio: 0.46 GF Score: 0/100

Q2 2023 Scandion Oncology A/S Earnings Call Transcript

Aug 23, 2023 / 08:00AM GMT
Release Date Price: €0.044323 (+2.49%)
Operator

Welcome to Scandion Oncology Q2-Report 2023. (Operator Instructions) Now, I will hand the conference over to CEO, Francois Martelet; and CFO, Johnny Stilou. Please go ahead.

Francois Martelet;S;CEO
Scandion Oncology A

/-

Thank you very much, and good morning to everyone, and welcome to our Q2-2023 interim-report investor call. You heard my name Francois Martelet, I'm the CEO of Scandion Oncology. With me today is our Chief Financial Officer, Johnny Stilou. Johnny and I will be updating you on the development and financial results for the second quarter of 2023, as well as recent events post quarter.

We had indeed a good second quarter in which we maintained our strong operational momentum and made several efforts to derisk our development pipeline, and therefore, as such, our company. And I will speak about that in more details shortly.

Following our presentation, Johnny and I are delighted to answer any question you may have. Please be informed that to best address your questions, we ask you to state this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot